NICE recommends these early in treatment for many people with established cardiovascular disease or chronic kidney disease [3] Pioglitazone : An insulin sensitiser, though less commonly used due to side effects including weight gain and fluid retention DPP-4 inhibitors : These enhance incretin activity with a lower side effect burden than GLP-1 agonists but less weight loss benefit Tirzepatide : A newer dual GIP/GLP-1 receptor agonist available for type 2 diabetes (subject to local formulary approval) [3] For patients who cannot tolerate or do not respond adequately to Ozempic, other GLP-1 receptor agonists such as dulaglutide (Trulicity) or liraglutide (Victoza) may be considered
Two were classified as recommended evidence, five as weak evidence, and 13 as poor evidence (Supplementary Table S6)
The reason behind this is not only based on the medication itself, but also on the dosage strength, treatment duration, clinic protocol, consultation fees , and level of medical supervision provided
Accessible labels and containers If your prescription label is hard to read, talk with your doctor or pharmacist
There are no contraindications in the prescribing information that prevent its use in people whove had bariatric procedures
Every vial ships with a third-party COA confirming blend composition, component purity, and compound identity verification